According to the deep-dive market assessment study conducted by Growth+Reports, the global cancer therapeutics market was pegged at ~US$ 112.8 billion in 2020. The market is expected to witness a CAGR of ~7.5% from 2021 to 2031.
The high cost of cancer treatment is expected to restrain the market growth to a certain extent. As cancer survival rates rise, so do the price tags of life-saving treatments. Many patients struggle with the physical and emotional effects of high out-of-pocket medical costs. Low-income families, who are uninsured or underinsured, face medical bills more than four times their annual salaries and cannot afford the rising costs of cancer treatments. According to a 2019 survey conducted by The Mesothelioma Centre at Asbestos.com, 63% of cancer patients and relatives reported financial struggles following a cancer diagnosis. Prominent players are progressively taking collaborative initiatives with several organizations, research centres & companies in order to encourage R&D of novel cancer treatment.
To access the Sample PDF of this research study, please request here: https://growthplusreports.com/inquiry/request-sample/cancer-therapeutics-market/7624
The report includes an in-depth study of the global market Cancer Therapeutics, where segments and sub-segments are analysed in quite a detail. This research will help players focus on high-growth segments and modify their business strategies if needed. The Cancer Therapeutics global market is segmented based on Products, Technology, and End Users. The regional segmentation research presented in the report provides players with valuable insights and data regarding key geographic markets such as North America, Europe, Asia Pacific, and the Rest of the World (RoW). Our researchers and analysts use reliable primary and secondary sources for research and data.
Some of the prominent players operating in the Cancer Therapeutics market includes: -
 Merck Sharp & Dohme Corp
 Novartis AG
 Pfizer Inc
 Bristol-Myers Squibb Company
 Johnson & Johnson Services, Inc
 Bayer AG
 F. Hoffmann-La Roche Ltd
 AstraZeneca
 Amgen Inc
 Lilly USA
 LLC, among others